CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.
Imanishi M, Inoue T, Fukushima K, Yamashita R, Nakayama R, Nojima M, Kondo K, Gomi Y, Tsunematsu H, Goto K, Miyamoto L, Funamoto M, Denda M, Ishizawa K, Otaka A, Fujino H, Ikeda Y, Tsuchiya K.
Imanishi M, et al. Among authors: tsunematsu h.
J Pharmacol Sci. 2023 Dec;153(4):232-242. doi: 10.1016/j.jphs.2023.10.003. Epub 2023 Oct 17.
J Pharmacol Sci. 2023.
PMID: 37973221
Free article.